OBJECTIVES: Parent engagement in anti-smoking parenting practices was examined as a predictor of children's recalled exposure to these practices, the presence of pro-smoking risk factors in children's social environments, and children's odds of initiating smoking. METHODS: 1,032 parents reported level of engagement in a program that promoted anti-smoking parenting practices for 8-year-old children. 1,032 children were surveyed 6 months and 3 years post-intervention; they reported on exposure to anti-smoking parenting practices, pro-smoking risk factors, and initiation of smoking. RESULTS: If parents reported high engagement in anti-smoking socialization, children had significantly greater recall of anti-smoking parenting practices and significantly fewer pro-smoking risk factors up to 3 years post-intervention. If engagement was moderate or low, children had progressively lower odds of recalling anti-smoking parenting practices relative to controls and they were progressively less likely to differ from controls in exposure to pro-smoking risk factors at follow-up. CONCLUSIONS: Achieving full program implementation remains a significant challenge to home-based, parent-led approaches to smoking prevention. However, if parents fully engage in anti-smoking parenting practices, children demonstrate protective effects up to 3 years later
Anti-smoking parenting practices
Recall by and effect on children's risk of smoking after 3 years
Jackson, C., & Dickinson, D. (2011). Anti-smoking parenting practices: Recall by and effect on children's risk of smoking after 3 years. International Journal of Public Health, 56(3), 263-270. https://doi.org/10.1007/s00038-010-0227-3
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Epigenetic biomarkers for smoking cessation
A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood